Jazz Pharmaceuticals plc Insider Trading

JAZZ

Last 12 months

Insiders sold $71.1M and bought nothing on the open market.

49% of the selling was scheduled in advance under 10b5-1 plans. Director Bruce C Cozadd sold $13.8M on Nov 26, 2025, 16% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2025.

Net open-market

−$71.1M

0 buys · 32 sales

Under a 10b5-1 plan

49%

of the value sold

Insiders who bought / sold

0 / 11

executives and directors

Last open-market buy

May 2025

May 12, 2025

Get an email when JAZZ's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Nov 2	Bruce C Cozadd Director	Sold10b5-1 plan	6,000	$215.84	$1.3M	1.7%	Form 4
Oct 6	Renee D Gala President & CEO	Sold10b5-1 plan	2,000	$236.40	473K	1.4%	Form 4
Oct 1	Bruce C Cozadd Director	Sold10b5-1 plan	6,000	$230.33	$1.38M	1.7%	Form 4
Sep 10	Neena M Patil EVP & Chief Legal Officer	Sold10b5-1 plan	1,200	$240.94	289K	2.5%	Form 4
Sep 8	Renee D Gala President & CEO	Sold10b5-1 plan	2,000	$243.03	486K	1.4%	Form 4
Sep 1	Bruce C Cozadd Director	Sold10b5-1 plan	6,000	$250.13	$1.5M	1.7%	Form 4
Aug 27	Robert Iannone EVP, Global Head of R&D & CMO	Sold10b5-1 plan 6 parts	76,921	$249.70 average	$19.2M	54%	Form 4
Aug 3	Bruce C Cozadd Director	Sold10b5-1 plan	6,000	$252.98	$1.52M	1.6%	Form 4
Jul 1	Bruce C Cozadd Director	Sold10b5-1 plan	6,000	$240.47	$1.44M	1.6%	Form 4
Jun 15	Mark Douglas Smith Director	Sold10b5-1 plan	1,157	$230.55	267K	11%	Form 4
Jun 10	Neena M Patil EVP & Chief Legal Officer	Sold10b5-1 plan	1,200	$231.83	278K	2.3%	Form 4
Jun 1	Bruce C Cozadd Director	Sold10b5-1 plan	6,000	$235.12	$1.41M	1.6%	Form 4
May 28	Samantha Pearce EVP, Chief Commercial Officer	SoldNo plan	6,907	$235.41	$1.63M	12%	Form 4
May 28	Neena M Patil EVP & Chief Legal Officer	Sold10b5-1 plan	1,192	$236.97	282K	2.2%	Form 4
May 22	Heather Ann McSharry Director	SoldNo plan	2,000	$241.00	482K	9.8%	Form 4
May 22	Rick E Winningham Director	SoldNo plan	2,741	$241.57	662K	22%	Form 4
May 1	Bruce C Cozadd Director	Sold10b5-1 plan	6,000	$203.33	$1.22M	1.6%	Form 4
Apr 1	Bruce C Cozadd Director	Sold10b5-1 plan 3 parts	6,000	$190.50 average	$1.14M	1.5%	Form 4
Mar 9	Patricia Carr SVP, Chief Accounting Officer	SoldNo plan	1,287	$182.94	235K	17%	Form 4
Mar 3	Bruce C Cozadd Director	Sold10b5-1 plan 3 parts	6,000	$186.44 average	$1.12M	1.5%	Form 4
Feb 26 – 27	Patricia Carr SVP, Chief Accounting Officer	SoldNo plan 2 parts	2,370	$192.60 average	456K	20%	Form 4
Feb 27	Norbert G Riedel Director	SoldNo plan	3,415	$192.00	656K	16%	Form 4
Feb 26	Mary Elizabeth Henderson SVP, Technical Operations	SoldNo plan	5,343	$194.49	$1.04M	16%	Form 4
Feb 26	Neena M Patil EVP & Chief Legal Officer	SoldNo plan 11 parts	55,600	$191.56 average	$10.7M	49%	Form 4
Dec 9, 2025	Mary Elizabeth Henderson SVP, Technical Operations	SoldNo plan	2,238	$169.51	379K	10%	Form 4
Dec 5, 2025	Patricia Carr SVP, Chief Accounting Officer	SoldNo plan 2 parts	4,660	$171.20 average	798K	40%	Form 4
Nov 26, 2025	Bruce C Cozadd Director	SoldNo plan 4 parts	77,500	$177.81 average	$13.8M	16%	Form 4
Nov 20, 2025	Heather Ann McSharry Director	SoldNo plan	3,415	$177.78	607K	14%	Form 4
Nov 18, 2025	Patricia Carr SVP, Chief Accounting Officer	SoldNo plan 2 parts	5,319	$182.06 average	968K	43%	Form 4
Nov 18, 2025	Rick E Winningham Director	SoldNo plan	5,500	$180.86	995K	38%	Form 4
Nov 18, 2025	Bruce C Cozadd Director	SoldNo plan 4 parts	18,000	$181.09 average	$3.26M	4.4%	Form 4
Nov 17, 2025	Robert Iannone EVP, Global Head of R&D & CMO	Sold10b5-1 plan	7,159	$168.26	$1.2M	9.0%	Form 4
Oct 1, 2025 – Oct 3, 2025	Bruce C Cozadd Director	Sold10b5-1 plan 2 parts	5,500	$137.01 average	754K	1.3%	Form 4
Sep 2, 2025	Bruce C Cozadd Director	Sold10b5-1 plan 2 parts	6,000	$128.62 average	772K	1.4%	Form 4
Aug 1, 2025	Bruce C Cozadd Chairman & CEO	Sold10b5-1 plan	1,000	$113.21	113K	0.2%	Form 4
Jul 1, 2025	Bruce C Cozadd Chairman & CEO	Sold10b5-1 plan 2 parts	1,000	$107.63 average	108K	0.2%	Form 4
Jun 2, 2025 – Jun 3, 2025	Bruce C Cozadd Chairman & CEO	Sold10b5-1 plan 2 parts	1,000	$108.95 average	109K	0.2%	Form 4
May 9, 2025 – May 12, 2025	Seamus Mulligan Director	Bought 4 parts	101,621	$98.33 average	$9.99M	8.6%	Form 4
May 1, 2025 – May 2, 2025	Bruce C Cozadd Chairman & CEO	Sold10b5-1 plan 2 parts	1,500	$117.57 average	176K	0.3%	Form 4
Apr 1, 2025	Bruce C Cozadd Chairman & CEO	Sold10b5-1 plan	1,500	$123.75	186K	0.3%	Form 4

Nov 210b5-1 plan
Bruce C Cozadd
Director · sold 6,000 at $215.84
$1.3M
1.7% of stake
Oct 610b5-1 plan
Renee D Gala
President & CEO · sold 2,000 at $236.40
473K
1.4% of stake
Oct 110b5-1 plan
Bruce C Cozadd
Director · sold 6,000 at $230.33
$1.38M
1.7% of stake
Sep 1010b5-1 plan
Neena M Patil
EVP & Chief Legal Officer · sold 1,200 at $240.94
289K
2.5% of stake
Sep 810b5-1 plan
Renee D Gala
President & CEO · sold 2,000 at $243.03
486K
1.4% of stake
Sep 110b5-1 plan
Bruce C Cozadd
Director · sold 6,000 at $250.13
$1.5M
1.7% of stake
Aug 2710b5-1 plan
Robert Iannone
EVP, Global Head of R&D & CMO · sold 76,921 at avg $249.70
$19.2M
54% of stake
Aug 310b5-1 plan
Bruce C Cozadd
Director · sold 6,000 at $252.98
$1.52M
1.6% of stake
Jul 110b5-1 plan
Bruce C Cozadd
Director · sold 6,000 at $240.47
$1.44M
1.6% of stake
Jun 1510b5-1 plan
Mark Douglas Smith
Director · sold 1,157 at $230.55
267K
11% of stake
Jun 1010b5-1 plan
Neena M Patil
EVP & Chief Legal Officer · sold 1,200 at $231.83
278K
2.3% of stake
Jun 110b5-1 plan
Bruce C Cozadd
Director · sold 6,000 at $235.12
$1.41M
1.6% of stake
May 28No plan
Samantha Pearce
EVP, Chief Commercial Officer · sold 6,907 at $235.41
$1.63M
12% of stake
May 2810b5-1 plan
Neena M Patil
EVP & Chief Legal Officer · sold 1,192 at $236.97
282K
2.2% of stake
May 22No plan
Heather Ann McSharry
Director · sold 2,000 at $241.00
482K
9.8% of stake
May 22No plan
Rick E Winningham
Director · sold 2,741 at $241.57
662K
22% of stake
May 110b5-1 plan
Bruce C Cozadd
Director · sold 6,000 at $203.33
$1.22M
1.6% of stake
Apr 110b5-1 plan
Bruce C Cozadd
Director · sold 6,000 at avg $190.50
$1.14M
1.5% of stake
Mar 9No plan
Patricia Carr
SVP, Chief Accounting Officer · sold 1,287 at $182.94
235K
17% of stake
Mar 310b5-1 plan
Bruce C Cozadd
Director · sold 6,000 at avg $186.44
$1.12M
1.5% of stake
Feb 26 – 27No plan
Patricia Carr
SVP, Chief Accounting Officer · sold 2,370 at avg $192.60
456K
20% of stake
Feb 27No plan
Norbert G Riedel
Director · sold 3,415 at $192.00
656K
16% of stake
Feb 26No plan
Mary Elizabeth Henderson
SVP, Technical Operations · sold 5,343 at $194.49
$1.04M
16% of stake
Feb 26No plan
Neena M Patil
EVP & Chief Legal Officer · sold 55,600 at avg $191.56
$10.7M
49% of stake
Dec 9, 2025No plan
Mary Elizabeth Henderson
SVP, Technical Operations · sold 2,238 at $169.51
379K
10% of stake
Dec 5, 2025No plan
Patricia Carr
SVP, Chief Accounting Officer · sold 4,660 at avg $171.20
798K
40% of stake
Nov 26, 2025No plan
Bruce C Cozadd
Director · sold 77,500 at avg $177.81
$13.8M
16% of stake
Nov 20, 2025No plan
Heather Ann McSharry
Director · sold 3,415 at $177.78
607K
14% of stake
Nov 18, 2025No plan
Patricia Carr
SVP, Chief Accounting Officer · sold 5,319 at avg $182.06
968K
43% of stake
Nov 18, 2025No plan
Rick E Winningham
Director · sold 5,500 at $180.86
995K
38% of stake
Nov 18, 2025No plan
Bruce C Cozadd
Director · sold 18,000 at avg $181.09
$3.26M
4.4% of stake
Nov 17, 202510b5-1 plan
Robert Iannone
EVP, Global Head of R&D & CMO · sold 7,159 at $168.26
$1.2M
9.0% of stake
Oct 1, 2025 – Oct 3, 202510b5-1 plan
Bruce C Cozadd
Director · sold 5,500 at avg $137.01
754K
1.3% of stake
Sep 2, 202510b5-1 plan
Bruce C Cozadd
Director · sold 6,000 at avg $128.62
772K
1.4% of stake
Aug 1, 202510b5-1 plan
Bruce C Cozadd
Chairman & CEO · sold 1,000 at $113.21
113K
0.2% of stake
Jul 1, 202510b5-1 plan
Bruce C Cozadd
Chairman & CEO · sold 1,000 at avg $107.63
108K
0.2% of stake
Jun 2, 2025 – Jun 3, 202510b5-1 plan
Bruce C Cozadd
Chairman & CEO · sold 1,000 at avg $108.95
109K
0.2% of stake
May 9, 2025 – May 12, 2025
Seamus Mulligan
Director · bought 101,621 at avg $98.33
$9.99M
8.6% of stake
May 1, 2025 – May 2, 202510b5-1 plan
Bruce C Cozadd
Chairman & CEO · sold 1,500 at avg $117.57
176K
0.3% of stake
Apr 1, 202510b5-1 plan
Bruce C Cozadd
Chairman & CEO · sold 1,500 at $123.75
186K
0.3% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch JAZZ, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with JAZZ

CompareIntrinsic value

ELANElanco Animal Health Incorporated

$25.31+3.01%46

PRGOPerrigo Company plc

$15.83+0.83%17

ALNYAlnylam Pharmaceuticals Inc

$161.08+0.74%81

BMRNBiomarin Pharmaceutical Inc.

$57.13+2.64%47

OGNOrganon & Co.

$13.83-0.14%28

ONCBeOne Medicines Ltd.

$377.78+6.42%65

UTHRUnited Therapeutics Corporation

$608.49+1.19%78

AMRXAmneal Pharmaceuticals Inc.

$19.95-1.29%57

Held by ETFs

JAZZ is in 164 US ETFs. The largest of them, with JAZZ's weight in each:

Spot a number that looks wrong? Check it in JAZZ's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing JAZZ

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.